Inici › Colitis ulcerosa › Texas › Houston
Assaigs clínics de Colitis ulcerosa a Houston, TX
17 estudis de Colitis ulcerosa busquen participants en centres de Houston i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
ReclutantFase 2
- Integrity Advanced Therapeutics /ID# 283871, Houston
- Novel Research - Bellaire /ID# 280925, Bellaire · a 7 mi
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
ReclutantFase 4
- Kelsey Research Foundation, Houston
- MedCare Pharma LLC, Houston
- Spring Clinical Research, Houston
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 2
- Baylor College of Medicine, Houston
- Intergrity Research, Houston
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
ReclutantFase 1/2Voluntaris sans benvinguts
- Xencor Investigative Site, Houston
- Xencor Investigative Site, Houston
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 2
- Site US-030, Houston
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 3
- Victorium Clinical Research, Houston
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
ReclutantFase 2/3
- Texas Children's Hospital, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
ReclutantFase 1
- UT MD Anderson Cancer Center, Houston
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
ReclutantFase 2
- Integrity Advanced Therapeutics, Houston
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
ReclutantFase 4
- The University of Texas Health Science Center at Houston, Houston
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
ReclutantEstudi observacional
- BAMC, Houston
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
ReclutantFase 2
- Baylor College of Medicine, Houston
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Reclutant
- Baylor College of Medicine, Houston
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
ReclutantEstudi observacional
- Houston Endoscopy & Research Center, Houston
- BI Research Center, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
ReclutantEstudi observacional
- M D Anderson Cancer Center, Houston
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
ReclutantFase 3
- Texas Children's Hospital - Baylor - PIN, Houston
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
ReclutantFase 2
- Mirador Therapeutics Selected Site, Houston
Assaigs de Colitis ulcerosa en altres ciutats
- New York City, NY23 estudis
- Orlando, FL22 estudis
- Miami, FL21 estudis
- San Antonio, TX16 estudis
- Tacoma, WA15 estudis
- Chicago, IL15 estudis
- San Diego, CA15 estudis
- Tyler, TX14 estudis
- Colorado Springs, CO14 estudis
- Los Angeles, CA13 estudis
- St. Louis, MO13 estudis
- Washington, DC12 estudis
Altres estudis a Houston
- Càncer de pulmó de cèl·lules no petites145 estudis
- Càncer de mama126 estudis
- Càncer (tots els tipus)121 estudis
- Càncer metastàtic104 estudis
- Càncer colorrectal102 estudis
- Càncer d'ovari89 estudis
- Leucèmia mieloide aguda85 estudis
- Càncer de pulmó78 estudis
- Càncer de pròstata76 estudis
- Càncer d'endometri68 estudis
- Càncer de pàncrees61 estudis
- Melanoma59 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.